β
Outcome MeasureOther

WAI-SR

Working Alliance Inventory – Short Revised

1 Paper in Blossom

Clinical Thresholds

1260
Poor alliance
Score 12–30
Moderate alliance
Score 31–45
Strong alliance
Score 46–60

Outcome Data Across Studies

Reported results for WAI-SR across 1 study with quantitative data.

Outcome data across 6 study arm–timepoint observations
SD
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Immediate Treatment(experimental)013———
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Delayed Treatment(experimental)011———
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Immediate Treatment(experimental)1413———
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Delayed Treatment(experimental)1411———
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Immediate Treatment(experimental)2113———
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder
2024Exploratory
Delayed Treatment(experimental)2111———

Papers Using WAI-SR

Open Accessindividual

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder

In a randomised, waiting‑list‑controlled psilocybin‑assisted therapy trial for major depressive disorder (N = 24), therapeutic alliance strengthened over time and higher alliance ratings before and shortly after dosing predicted stronger acute mystical and psychological‑insight experiences and significantly greater reductions in depressive symptoms up to 12 months. These results highlight the therapeutic relationship as an important predictor of both acute psychedelic experiences and long‑term clinical outcomes.

Published
Journal
PLOS ONE
Authors
Levin, A. W., Lancelotta, R., Sepeda, N. D., Gukasyan, N., Nayak, S., Wagener, T. L., Barrett, F. S., Griffiths, R. R., Davis, A. K.

Quick Facts

Full Name
Working Alliance Inventory – Short Revised
Domain
Other
Papers Indexed
1
Score Range
12–60
Interpretation
Higher = better
Unit
points
All Measures